Stay updated on Perseus Study: Daratumumab vs Standard in Untreated Myeloma Clinical Trial
Sign up to get notified when there's something new on the Perseus Study: Daratumumab vs Standard in Untreated Myeloma Clinical Trial page.

Latest updates to the Perseus Study: Daratumumab vs Standard in Untreated Myeloma Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedAdded related topics: Multiple myeloma and MedlinePlus Genetics; the page revision updated to v3.3.3. Removed the HHS Vulnerability Disclosure link and updated the footer revision from v3.3.2.SummaryDifference0.2%

- Check20 days agoChange DetectedRemoved related topics links for 'Multiple Myeloma' and 'MedlinePlus Genetics' from the page. This affects navigation references but does not modify core trial content.SummaryDifference0.1%

- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedRevision updated from v3.3.1 to v3.3.2 in the page footer. No other visible changes to the study details or page layout.SummaryDifference0.0%

- Check41 days agoChange DetectedAdded 'Multiple myeloma' and related topics (MedlinePlus Genetics). Included a note that publications are automatically filled from PubMed and updated the revision tag to v3.3.1.SummaryDifference0.2%

- Check49 days agoChange DetectedRemoved the site-wide notice about government funding and NIH operating status from the page, which previously informed users about potential delays and the center's operations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check63 days agoChange DetectedDeleted the 'Multiple myeloma' topic and its related 'MedlinePlus Genetics' link from the Related Topics section. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

Stay in the know with updates to Perseus Study: Daratumumab vs Standard in Untreated Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Perseus Study: Daratumumab vs Standard in Untreated Myeloma Clinical Trial page.